Preoperative Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Test at Between 48 and 72 Hours Preoperatively is Safe for Patients Undergoing Primary and Revision Hip and Knee Arthroplasty: A Multicentre International Study
- PMID: 35307532
- PMCID: PMC8928746
- DOI: 10.1016/j.arth.2022.03.049
Preoperative Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Test at Between 48 and 72 Hours Preoperatively is Safe for Patients Undergoing Primary and Revision Hip and Knee Arthroplasty: A Multicentre International Study
Abstract
Background: Patients undergoing lower limb arthroplasty who are severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive at the time of surgery have a high risk of mortality. The National Institute for Health and Clinical Care Excellence and the British Orthopaedic Association advise self-isolation for 14 days preoperatively in patients at a high risk of adverse outcomes due to COVID-19. The aim of the study is to assess whether preoperative polymerase chain reaction (PCR) for SARS-CoV-2 could be performed at between 48 and 72 hours preoperatively with specific advice about minimizing the risk of SARS-CoV-2 restricted to between PCR and admission.
Methods: A multicentre, international, observational cohort study of 1,000 lower limb arthroplasty cases was performed. The dual primary outcomes were 30-day conversion to SARS-CoV-2 positive and 30-day SARS-CoV-2 mortality. Secondary outcomes included 30-day SARS-CoV-2 morbidity.
Results: Of the 1,000 cases, 935 (94%) had a PCR between 48 and 72 hours preoperatively. All cases were admitted to and had surgery through a COVID-free pathway. Primary knee arthroplasty was performed in 41% of cases, primary hip arthroplasty in 40%, revision knee arthroplasty in 11%, and revision hip arthroplasty in 9%. Six percent of operations were emergency operations. No cases of SARS-CoV-2 were identified within the first 30 days.
Conclusion: Preoperative SARS-CoV-2 PCR test between 48 and 72 hours preoperatively with advice about minimizing the risk of SARS-CoV-2 restricted to between PCR and admission in conjunction with a COVID-free pathway is safe for patients undergoing primary and revision hip and knee arthroplasty. Preoperative SARS-CoV-2 PCR test alone may be safe but further adequately powered studies are required. This information is important for shared decision making with patients during the current pandemic.
Keywords: COVID-19; SARS-CoV-2; morbidity; mortality; orthopedic surgery; patient outcomes.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- British Orthopaedic Association Re-starting non-urgent trauma and orthopaedic care: summary guidance. https://www.boa.ac.uk/static/f20a4693-13c9-4e23-9e35207f2bbc0060/BOA-Gui... [accessed 01.05.21]
-
- British Orthopaedic Association Statement regarding NICE COVID-19 rapid guideline on arranging planned care. https://www.boa.ac.uk/static/26d555f9-3dfc-45ad-81aa967e831149b1/BOA-sta... [accessed 01.05.21]
-
- Carr A., Smith J., A., Camaradou J., Prieto-Alhambra D. Growing backlog of planned surgery due to Covid-19. BMJ. 2021;372:n339. - PubMed
-
- Clement N.D., Scott C.E.H., Murray J.R.D., Howie C.R., Deehan D.J., IMPACT-Restart Collaboration The number of patients “worse than death” while waiting for a hip or knee arthroplasty has nearly doubled during the COVID-19 pandemic. Bone Joint J. 2021;103-B:672–680. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
